Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

366
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
366
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

787
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
787
Schizophrenia01:17

Schizophrenia

165
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
165
Positive Symptoms of Schizophrenia: Hallucinations and Delusions01:30

Positive Symptoms of Schizophrenia: Hallucinations and Delusions

191
Schizophrenia is a complex mental health disorder that can manifest with various positive symptoms, including thought, movement, and behavior disorders. These symptoms significantly disrupt cognitive and motor functions, leading to profound effects on an individual's ability to engage with the world.
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...
191
Positive Symptoms Schizophrenia: Hallucinations and Delusions01:26

Positive Symptoms Schizophrenia: Hallucinations and Delusions

110
Schizophrenia is a complex psychiatric disorder characterized by a range of symptoms that significantly impact cognition, behavior, and emotional regulation. Among these, the positive symptoms stand out as they involve the addition or exaggeration of normal mental functions, deviating markedly from typical behavior and perception. Hallucinations and delusions are prominent positive symptoms, each profoundly affecting the individual's experience of reality.
Hallucinations
Hallucinations in...
110
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

173
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
173

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigating the toll of childhood socioeconomic disadvantage on adolescent mental health in three UK cohorts.

JCPP advances·2026
Same author

PICCOS: study protocol for pressurised intraperitoneal aerosolised chemotherapy (PIPAC) in the management of cancers of the colon, ovary and stomach: a randomised controlled, phase II trial of efficacy in peritoneal metastases.

Pleura and peritoneum·2026
Same author

Social deprivation in adolescence and risk of depression in young adulthood: a longitudinal analysis of linked administrative data from Northern Ireland.

Social psychiatry and psychiatric epidemiology·2026
Same author

The relationship between social mobility and mortality: analysis of intercensal data (1991, 2001, and 2011).

European journal of public health·2026
Same author

Putting Voluntary, Charity, and Social Enterprise (VCSE) Organisations at the Heart of Research: Creating a Northern Ireland VCSE Research Directory.

International journal of population data science·2026
Same author

Accreta Program Surgeon Inclusivity: Reply to "Letter to the Editor regarding 'Perioperative Outcomes of Maternal Fetal Medicine Specialist as Primary Surgeon for Placenta Accreta Spectrum Hysterectomies'".

American journal of obstetrics & gynecology MFM·2026

Related Experiment Video

Updated: Aug 1, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.2K

Functioning, symptom expression and risk along the psychosis continuum.

Sarah Butter1,2, Mark Shevlin1, Orla McBride1

  • 1School of Psychology, Ulster University, Coleraine, Northern Ireland.

Psychological Medicine
|April 24, 2023
PubMed
Summary

Subclinical psychotic experiences (PEs) exist on a continuum, with distressing PEs and diagnosed psychotic disorders showing poorer functioning and distinct symptom profiles compared to non-distressing PEs. Risk factors like trauma and mental health diagnoses vary across this psychosis spectrum.

Keywords:
Continuumfunctioningneed for carepsychosisrisk factorsschizotypal

More Related Videos

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
05:52

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis

Published on: November 21, 2013

15.0K
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

6.7K

Related Experiment Videos

Last Updated: Aug 1, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.2K
Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
05:52

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis

Published on: November 21, 2013

15.0K
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

6.7K

Area of Science:

  • Psychiatry and Mental Health
  • Epidemiology
  • Psychosis Research

Background:

  • The psychosis continuum model suggests subclinical psychotic experiences (PEs) can be distinguished from clinical disorders by the absence of a 'need for care'.
  • Understanding the spectrum of psychosis is crucial for accurate diagnosis and intervention.

Purpose of the Study:

  • To examine variations in functioning, symptomology, and etiological risk across the psychosis phenotype, from no PEs to diagnosed psychotic disorders.
  • To investigate how risk factors and symptom expression differ across distinct levels of the psychosis continuum.

Main Methods:

  • Utilized data from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) with 34,653 participants.
  • Categorized participants into four groups: No PEs, PE-Experienced Only, PE-Impaired, and Diagnosed psychotic disorder.
  • Analyzed differences in functioning, symptom endorsement, and etiological risk factors among these groups.

Main Results:

  • A graded trend was observed, with the Diagnosed group exhibiting the poorest functioning, followed by PE-Impaired, then PE-Experienced Only, compared to No PEs.
  • The PE-Impaired group reported endorsing more PEs than the PE-Experienced Only and Diagnosed groups.
  • Trauma, current mental health diagnoses (anxiety, depression), and drug use differentiated all continuum levels except the extreme end (PE-Impaired vs. Diagnosed).

Conclusions:

  • Findings support continuum-based interpretations of the psychosis phenotype, emphasizing the importance of considering gradual changes in impairment, symptom expression, and risk.
  • Highlights opportunities to refine understanding of how these factors evolve across the psychosis spectrum.
  • Suggests that interventions may need to be tailored to different points along the psychosis continuum.